"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
| Descriptor ID |
D007680
|
| MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
| Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 7 | 0 | 7 |
| 1999 | 4 | 0 | 4 |
| 2000 | 9 | 0 | 9 |
| 2001 | 7 | 2 | 9 |
| 2002 | 7 | 2 | 9 |
| 2003 | 6 | 1 | 7 |
| 2004 | 17 | 0 | 17 |
| 2005 | 9 | 3 | 12 |
| 2006 | 17 | 4 | 21 |
| 2007 | 15 | 4 | 19 |
| 2008 | 16 | 0 | 16 |
| 2009 | 23 | 1 | 24 |
| 2010 | 16 | 4 | 20 |
| 2011 | 8 | 2 | 10 |
| 2012 | 12 | 1 | 13 |
| 2013 | 16 | 3 | 19 |
| 2014 | 16 | 3 | 19 |
| 2015 | 14 | 0 | 14 |
| 2016 | 27 | 0 | 27 |
| 2017 | 10 | 2 | 12 |
| 2018 | 10 | 2 | 12 |
| 2019 | 13 | 0 | 13 |
| 2020 | 12 | 2 | 14 |
| 2021 | 14 | 2 | 16 |
| 2022 | 9 | 0 | 9 |
| 2023 | 7 | 0 | 7 |
| 2024 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1/TSC2-Mutations: A Series of 4 cases and a review of the literature. Hum Pathol. 2024 Nov; 153:105680.
-
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting. Urol Oncol. 2025 Mar; 43(3):135-146.
-
Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. Virchows Arch. 2024 Nov; 485(5):829-840.
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. N Engl J Med. 2024 Aug 22; 391(8):710-721.
-
Cytopathology and clinicopathological correlation of renal neuroendocrine neoplasms. J Am Soc Cytopathol. 2024 Nov-Dec; 13(6):406-412.
-
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability. Elife. 2024 May 24; 13.
-
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis. J Clin Invest. 2024 Apr 15; 134(8).
-
Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance. Adv Anat Pathol. 2024 May 01; 31(3):157-168.
-
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma. Invest New Drugs. 2024 Apr; 42(2):179-184.
-
Actual encounters of the kidney kind: Exploring 48 cases of renal collision tumors through the lens of literature. Hum Pathol. 2024 03; 145:26-33.